Rhizoma Panacis majori reduces toxicity of chemotherapy in S180-bearing mice

Journal of Chinese Integrative Medicine

Volumn 6, Issue 12, 2008, Pages 1255-1258

  Chen, Tao ^a   Gong, Zhang Bin ^b   Fu, Ya Ling ^a  

^a Medical College of Three Gorges University   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chemotherapy; Codonopsis convolvulacea; Mice; Sarcoma 180

Indexed keywords

FLUOROURACIL; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE; LEUKOCYTE COUNT; LIFESPAN; MEDICINAL PLANT; MOUSE; NONHUMAN; PANACIS MAJORI; PLANT ROOT; RETICULOCYTE; SARCOMA; SARCOMA 180; TOXICITY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DRUGS, CHINESE HERBAL; FEMALE; FLUOROURACIL; MALE; MICE; MICE, INBRED STRAINS; SARCOMA 180;

EID: 65349135396     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20081209     Document Type: Article

References (6)

1. Duan JY, Chen RM. Effect of Rhizoma Panacis majoris on blood and hematopoiesis function. Xi Bei Yao Xue Za Zhi. 1996; 11(2): 72-73.
2. Zeng Y, Luo G, Yang WJ, et al. Inhibitory effect of acetylshikonin injection on mouse S180 sarcoma. Zhong Yao Yao Li Yu Lin Chuang. 2008; 24 (1): 22-23. Chinese with abstract in English.
3. Chen XQ. New materia medica. Beijing: People's Medical Publishing House. 1998: 513.
4. Zhang XM. Pharmacology and clinical application of antitumor drugs. Zhengzhou: Henan Medical University Press. 1999: 129.
5. Chen XG, Han R, Yang ZC. Pharmacology and pharmacotherapeutics of anti-metabolism drugs. Beijing: People's Medical Publishing House. 2000: 1774.
6. Wang Q. Experimental methods of modern medicine. Beijing: People's Medical Publishing House. 1997: 1056.